FindTrial
Sign In

Investigation of endogenous ribose as a biomarker in related diseases

Investigation of endogenous ribose as a biomarker in related diseases

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DDD-17010722
Enrollment
Unknown
Registered
2017-02-24
Start date
2014-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic disorders

Interventions

Gold Standard:clinical outcome
Index test:serum&#32
ribose&#32
concentration,&#32
uric&#32
concentration

Sponsors

Institute of Biophysics, Chinese Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients suffering one kind of diseases such as diabetes, neurodegerative diseases, and their control people.

Exclusion criteria

Exclusion criteria: patients without definite diagnosis

Design outcomes

Primary

MeasureTime frame
uric ribose;serum ribose;plasma ribose;—

Countries

China

Contacts

Public ContactHe Rongqiao

Institute of Biophysics, China Academy of Sciences

rongqiaohe@163.com+86 010-64889876

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026